Zacks: Analysts Anticipate Integer Holdings Co. (ITGR) Will Post Quarterly Sales of $361.04 Million

Equities research analysts expect that Integer Holdings Co. (NYSE:ITGR) will report sales of $361.04 million for the current quarter, Zacks reports. Three analysts have made estimates for Integer’s earnings. The highest sales estimate is $361.63 million and the lowest is $360.00 million. Integer posted sales of $359.59 million in the same quarter last year, which suggests a positive year over year growth rate of 0.4%. The firm is expected to report its next earnings report on Monday, February 26th.

According to Zacks, analysts expect that Integer will report full year sales of $361.04 million for the current fiscal year. For the next fiscal year, analysts forecast that the business will post sales of $1.47 billion per share, with estimates ranging from $1.47 billion to $1.48 billion. Zacks’ sales averages are an average based on a survey of sell-side research firms that follow Integer.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, October 26th. The medical equipment provider reported $0.82 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.78 by $0.04. Integer had a return on equity of 11.22% and a net margin of 1.42%. The firm had revenue of $363.31 million during the quarter, compared to analysts’ expectations of $354.83 million. During the same period last year, the firm posted $0.83 EPS. The business’s revenue was up 4.8% on a year-over-year basis.

A number of equities research analysts recently weighed in on ITGR shares. TheStreet raised Integer from a “c+” rating to a “b-” rating in a report on Wednesday, October 18th. Northcoast Research cut Integer from a “buy” rating to a “neutral” rating in a report on Monday, October 23rd. They noted that the move was a valuation call. BidaskClub cut Integer from a “strong-buy” rating to a “buy” rating in a report on Saturday, October 28th. Royal Bank of Canada reaffirmed a “neutral” rating on shares of Integer in a report on Friday, October 27th. Finally, Zacks Investment Research raised Integer from a “sell” rating to a “buy” rating and set a $51.00 price target for the company in a report on Wednesday, December 27th. Five analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $51.00.

In other news, COO Jeremy Friedman sold 8,163 shares of Integer stock in a transaction on Wednesday, January 3rd. The stock was sold at an average price of $44.89, for a total value of $366,437.07. Following the completion of the sale, the chief operating officer now directly owns 17,673 shares of the company’s stock, valued at approximately $793,340.97. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jennifer M. Bolt sold 7,626 shares of Integer stock in a transaction on Tuesday, October 31st. The shares were sold at an average price of $48.22, for a total value of $367,725.72. Following the completion of the sale, the insider now directly owns 12,735 shares of the company’s stock, valued at $614,081.70. The disclosure for this sale can be found here. Insiders sold a total of 100,625 shares of company stock valued at $4,694,219 over the last three months. Insiders own 4.80% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. UBS Asset Management Americas Inc. increased its stake in shares of Integer by 0.5% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 18,967 shares of the medical equipment provider’s stock valued at $820,000 after buying an additional 98 shares during the period. TIAA CREF Investment Management LLC boosted its position in shares of Integer by 0.6% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 123,410 shares of the medical equipment provider’s stock worth $5,337,000 after purchasing an additional 740 shares during the last quarter. Strs Ohio boosted its position in shares of Integer by 5.3% in the 4th quarter. Strs Ohio now owns 21,900 shares of the medical equipment provider’s stock worth $992,000 after purchasing an additional 1,100 shares during the last quarter. Quantbot Technologies LP boosted its position in shares of Integer by 21.5% in the 3rd quarter. Quantbot Technologies LP now owns 6,255 shares of the medical equipment provider’s stock worth $319,000 after purchasing an additional 1,107 shares during the last quarter. Finally, Rhumbline Advisers boosted its position in shares of Integer by 2.0% in the 3rd quarter. Rhumbline Advisers now owns 61,908 shares of the medical equipment provider’s stock worth $3,167,000 after purchasing an additional 1,235 shares during the last quarter. 95.11% of the stock is owned by institutional investors.

Integer (NYSE ITGR) traded up $0.40 during mid-day trading on Monday, reaching $51.00. The company had a trading volume of 77,435 shares, compared to its average volume of 143,638. Integer has a 12-month low of $30.30 and a 12-month high of $55.20. The firm has a market cap of $1,602.49, a PE ratio of 80.95, a price-to-earnings-growth ratio of 1.06 and a beta of 1.08. The company has a debt-to-equity ratio of 1.95, a current ratio of 2.58 and a quick ratio of 1.37.

COPYRIGHT VIOLATION NOTICE: This story was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this story on another domain, it was illegally copied and reposted in violation of US & international copyright law. The legal version of this story can be read at https://stocknewstimes.com/2018/02/11/zacks-analysts-anticipate-integer-holdings-co-itgr-will-post-quarterly-sales-of-361-04-million.html.

Integer Company Profile

Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.

Get a free copy of the Zacks research report on Integer (ITGR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply